MREM Press Releases
3M Introduces Scotch(TM) Anti-Bacterial Premium Kitchen Scissors and Scotch(TM) Detachable Titanium Kitchen Scissors that Prevent Cross-Contamination During Food Preparation
KUALA LUMPUR. Malaysia, Dec 14 (Bernama-PRNewswire) — Global science company, 3M expands its kitchen scissors range with the launch of the Scotch™ Anti-Bacterial Premium Kitchen Scissors and Scotch™ Detachable Titanium Kitchen Scissors. Distinguished by three colours – red, green, and purple, for easy identification and prevention of cross-contamination, everybody can now
Yili Indonesia Dairy Production Base Launches First Phase of Operations, Creating a New Growth Hub for Southeast Asia
BEKASI CITY, Indonesia, Dec 14 (Bernama-AsiaNet) — – Yili opens its first self-built production base in Southeast Asia, marking a new milestone in its “global network” strategy– Yili’s Southeast Asia “Dual Centers” in Indonesia and Thailand are closely synergized to boost its business performance in the international market Inner Mongolia
Technology Transfer Apprenticeship Programme (TTAP) Completed, With Important Vehicle Data Collected For Industry Development
KUALA LUMPUR, Dec 14 (Bernama) — The Technology Transfer Apprenticeship Programme (TTAP) developed by Malaysia Automotive Robotics & IoT Institute (MARii) and Persona Energy Sdn Bhd reached its completion through the TTAP appreciation awards and handover ceremony, held at the Ministry of International Trade and Industry (MITI) on 13 December 2021. The TTAP is
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project
Seattle, Dec 14 (Bernama-GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with I-MAB Biopharma (Nasdaq: IMAB). The I-MAB treatment being developed is approaching late-phase clinical trials and AGC Biologics will manufacture the materials at its site in Seattle, while also
Positive Outlook from German Industry for Malaysia Towards Economic Recovery
Malaysia Remains as a Preferred Business Destination to German Companies KUALA LUMPUR, Dec 14 (Bernama) — Despite the economic downturn because of the pandemic, German companies are still very optimistic when it comes to doing business in Malaysia, according to the latest AHK World Business Outlook Fall 2021 survey results. http://mrem.bernama.com/viewsm.php?idm=41921
Adagene Presents Preclinical Data Showcasing Best-in-Class Profiles for ADG153, an Anti-CD47 SAFEbody® and ADG152, a CD20xCD3 Bispecific T-cell Engager POWERbody™
SAN DIEGO and SUZHOU, China, Dec 14 (Bernama-GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced preclinical data demonstrating the compelling differentiation of ADG153, an anti-CD47 monoclonal antibody (mAb), and ADG152, a CD20xCD3 bispecific T-cell engager
PETRONAS Inks Agreement with Savannah Energy to Sell Business Interests in Chad
KUALA LUMPUR, Dec 14 (Bernama) — PETRONAS (E&P) Overseas Venture Sdn Bhd has signed a Share Sale and Purchase Agreement (SPA) with Savannah Energy Chad Limited to sell its entire shareholding in PETRONAS Carigali Chad Exploration & Production Inc. (PCCEPI), its subsidiary in the Republic of Chad. The SPA includes
AXA Launches e-Claim for Fast Claim Submission & Tracking
KUALA LUMPUR, Dec 13 (Bernama) — As part of its continuous effort to enhance its services and better serve customers, AXA Affin General Insurance (AXA) has launched AXA e-Claim for its car policies to provide an easier, faster and more convenient way for customers to submit their car claim online.
Tessa Therapeutics Showcases Positive Clinical Data from Phase 1 Study of “Off the Shelf” CD30 Cell Therapy at 2021 Annual Meeting of American Society of Hematology (ASH)
Oral poster presentation highlights data from dose-escalation trial of allogeneic CD30.CAR EBVST cell therapy (TT11X) in patients with relapsed or refractory CD30-positive lymphomas Results demonstrate 77.8% overall response rate across dose levels with all complete responses at the highest dose level Therapy well tolerated with no dose-limiting toxicities observed SINGAPORE,
Juniper Research: Ride Sharing Spend By Consumers To Exceed $930 Billion Globally By 2026; Driven By Strong COVID-19 Recovery & Reduced Private Vehicle Usage
BASINGSTOKE, England, Dec 13 (Bernama-BUSINESS WIRE) — A new study by Juniper Research has found ride sharing spending by consumers globally will exceed $937 billion by 2026, comparable to 50 times the combined annual revenue of Transport for London, New York City’s MTA, and Beijing Metro in 2021. This spend represents an increase